This page is no longer being maintained and has not been updated since October 2023. The information on this page may be out of date and should only be used for historical reference
| Info |
|---|
This page contains COVID-19 related vaccine content created by Member countries and available in national SNOMED CT extensions/editions. SNOMED International itself has not been involved in the creation of this content and these concepts are not available in the International Edition of SNOMED CT. Updated: |
COVID-19 Vaccine Moderna messenger ribonucleic acid-1273 100 micrograms per 0.5 milliliter suspension for injection Moderna Therapeutics Inc. (real clinical drug)
| Advanced Tables - Table Plus | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 JANSSEN COVID-19 VACCINE Jan | CA | 28581000087106 | PFIZER-BIONTECH COVID-19 VACCINE messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 PFIZER-BIONTECH COVID-19 VACCINE mRNA PB | CA | 28571000087109 | COVID-19 Vaccine Moderna mRNA-1273 Mod | CA | 28761000087108 | ASTRAZENECA COVID-19 VACCINE 0.5 milliliter solution for injection AstraZeneca Canada Inc. (real clinical drug) | COVID-19 ASTRAZENECA COVID-19 VACCINE AZC | CA | 28961000087105 | COVISHIELD 0.5 milliliter solution for injection Verity Pharmaceuticals Inc. (real clinical drug) | COVID-19 COVISHIELD VP | CA | 29171000087106 (no link yet available) | NOVAVAX COVID-19 VACCINE 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) | not yet available | ES | 69961000122104 |
| adjuvant vaccine recombinant protein [Novavax] (medicinal product) | vacuna contra COVID-19 Adyuvada proteína recombinante [Novavax] (producto medicinal) | |||
ES | 69971000122109 | COVID-19 adjuvant vaccine recombinant protein [Sanofi Pasteur / GSK] (medicinal product) | vacuna contra COVID-19 Adyuvada proteína recombinante [Sanofi Pasteur / GSK] (producto medicinal) | |
ES | 69911000122102 | mRNA COVID-19 vaccine [BioNTech / Pfizer] (medicinal product) | vacuna contra COVID-19 ARNm [BioNTech / Pfizer] (producto medicinal) | |
ES | 69921000122108 | mRNA COVID-19 vaccine [Curevac] (medicinal product) | vacuna contra COVID-19 ARNm [Curevac] (producto medicinal) | |
ES | 69931000122106 | mRNA COVID-19 vaccine [Moderna / Lonza] (medicinal product) | vacuna contra COVID-19 ARNm [Moderna / Lonza] | |
ES | 69941000122103 | COVID-19 vaccine with Ad26 vector [J&J / Janssen] (medicinal product) | vacuna contra COVID-19 con vector Ad26 [J&J / Janssen] (producto medicinal) | |
ES | 69951000122101 | COVID-19 vaccine with ChAdOx1 vector [Oxford / AstraZeneca |
| ] (medicinal product) | vacuna contra COVID-19 |
| con vector ChAdOx1 [Oxford / AstraZeneca] (producto medicinal) |
IE |
| 1401000220108 | COVID-19 |
Vaccine AstraZeneca 5 x10,000,000,000 viral particles per 0.5ml dose for injection multidose vials (medicinal product) |
| COVID-19 |
| Vaccine AstraZeneca | ||||
IE | 1421000220104 | COVID-19 mRNA Vaccine Moderna 0.1mg per 0.5mL dose dispersion for injection multidose vials (medicinal product) | COVID-19 mRNA Vaccine Moderna | |
IE | 1411000220106 | COVID-19 mRNA Vaccine Pfizer-BioNTech 30 micrograms per 0.3ml dose concentrate for suspension for injection multidose vials |
(medicinal product) |
| COVID-19 |
| mRNA Vaccine Pfizer-BioNTech | ||
IE | 1591000220103 (no link yet available) | Janssen COVID-19 Vaccine 0.5 millilitre suspension injection Janssen Inc |
(medicinal product) |
| COVID-19 |
| Janssen Vaccine | ||||
IN | 997231000189107 | Covishield 0.5 milliliter/1 dose solution for injection Serum Institute of India Private Limited (real clinical drug) | Covishield vaccine | |
IN | 997201000189104 | Covaxin 0.5 milliliter/1 dose solution for injection Bharat Biotech International Limited (real clinical drug) | Covaxin vaccine | |
IN | 997261000189100 | Sputnik V 0.5 milliliter/1 dose solution for injection Dr.Reddy's Laboratories Limited (real clinical drug | Sputnik V vaccine | |
IN | 997271000189109 | Sputnik V 0.5 milliliter/1 dose solution for injection Panacea Biotec Limited (real clinical drug) | Sputnik V vaccine | |
CA | COMIRNATY messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY pediatric 10 mcg/0.2 ml mRNA PB | ||
CA | COMIRNATY messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug | COVID-19 COMIRNATY pediatric 3 mcg/0.2 ml mRNA PB | ||
CA | COMIRNATY messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY 30 mcg/0.3 ml mRNA PB | ||
CA | COMIRNATY vaccine messenger ribonucleic acid 30 micrograms per 0.3 milliliter tris-sucrose formulation suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY tris-sucrose 30 mcg/0.3 ml mRNA PB | ||
CA | COVIFENZ virus-like particle 3.75 micrograms per 0.5 milliliter emulsion for injection Medicago Inc. (real clinical drug) | COVID-19 COVIFENZ VLP MED | ||
CA | COVISHIELD non-replicant vector 0.5 milliliter solution for injection Verity Pharmaceuticals Inc. (real clinical drug) | COVID-19 COVISHIELD VP | ||
CA | JANSSEN COVID-19 VACCINE non-replicant vector 0.5 milliliter suspension for injection Janssen Inc. (real clinical drug) | COVID-19 JANSSEN COVID-19 VACCINE Jan | ||
CA | NUVAXOVID recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) | COVID-19 NUVAXOVID NOV | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.1) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX 0.10 mg/mL mRNA Mod | ||
CA | SPIKEVAX messenger ribonucleic acid 0.20 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX 0.20 mg/mL mRNA Mod | ||
CA | VAXZEVRIA non-replicant vector 0.5 milliliter solution for injection AstraZeneca Canada Inc. (real clinical drug) | COVID-19 VAXZEVRIA AZC | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COMIRNATY bivalent Original and Omicron BA.4/BA.5 30 mcg/0.3 mL mRNA | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Original & Omicron BA.4/BA.5 pediatric 10mcg/0.2mL PB | ||
CA | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 10 micrograms per 0.2 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) pediatric 10 mcg/0.2mL mRNA Mod | ||
CA | Pediatric vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) | COVID-19 pediatric mRNA unspecified | ||
CA | VidPrevtyn Beta recombinant spike protein 5 micrograms per 0.5 milliliter emulsion for injection Sanofi Pasteur Ltd. (real clinical drug) | COVID-19 VidPrevtyn Beta SP | ||
CA | COMIRNATY Original & Omicron BA.4/BA.5 messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Original & Omicron BA.4/BA.5 pediatric 3 mcg/0.2mL mRNA PB | ||
CA | CORBEVAX recombinant spike protein 0.5 milliliter suspension for injection Biological E. Limited (real clinical drug) | COVID-19 CORBEVAX BE | ||
CA | NUVAXOVID Omicron XBB.1.5 recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug) | COVID-19 NUVAXOVID Omicron XBB.1.5 NOV | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 30 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 30 mcg/0.3mL mRNA PB | ||
CA | SPIKEVAX XBB.1.5 messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Biopharma Canada Corporation (real clinical drug) | COVID-19 SPIKEVAX XBB.1.5 0.10 mg/mL mRNA MBCC | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 3 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 3 mcg/0.2 mL mRNA PB | ||
CA | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 10 micrograms per 0.3 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.3 mL mRNA PB | ||
CA | 51621000087101 | COMIRNATY Omicron XBB.1.5 messenger ribonucleic acid 10 micrograms per 0.2 milliliter suspension for injection BioNTech Manufacturing GmbH (real clinical drug) | COVID-19 COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.2 mL mRNA PB | |
AU | 1527311000168101 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein (medicinal product) | COVID-19 ChAdOx1-S viral vector vaccine | |
AU | 1530511000168108 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL injection, 4 mL vial (medicinal product unit of use) | COVID-19 ChAdOx1-S viral vector vaccine, 4 mL vial | |
AU | 1527321000168108 | chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | COVID-19 ChAdOx1-S viral vector vaccine, 5 mL vial | |
AU | 1591871000168100 | Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose (tozinameran 30 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1656521000168106 | Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose (tozinameran) injection, 0.4 mL vial (trade product unit of use) | Comirnaty Maroon Cap 6 Months to less than 5 Years Dilute to Use Multidose injection, 0.4 mL vial | |
AU | 1591711000168100 | Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose (tozinameran) injection, 1.3 mL vial (trade product unit of use) | Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 1.3 mL vial | |
AU | 1640431000168105 | Comirnaty Original/Omicron BA.1 Multidose (riltozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Original/Omicron BA.1 Multidose injection, 2.25 mL vial | |
AU | 1652631000168107 | Comirnaty Original/Omicron BA.4-5 Multidose (famtozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL) injection, 2.25 mL vial (trade product unit of use) | Comirnaty Original/Omicron BA.4-5 Multidose injection, 2.25 mL vial | |
AU | 1525041000168106 | Comirnaty Purple Cap Multidose (tozinameran) injection, 0.45 mL vial (trade product unit of use) | Comirnaty Purple Cap Multidose injection, 0.45 mL vial | |
AU | 1655191000168105 | davesomeran + elasomeran (medicinal product) | elasomeran + davesomeran | |
AU | 1659041000168103 | davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL injection, 0.5 mL syringe (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, syringe | |
AU | 1655201000168108 | davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + davesomeran 25 microgram/0.5 mL injection, 2.5 mL vial | |
AU | 1565221000168102 | elasomeran (medicinal product) | elasomeran | |
AU | 1632651000168102 | elasomeran + imelasomeran (medicinal product) | elasomeran + imelasomeran | |
AU | 1636281000168108 | elasomeran 100 microgram / 1 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 100 microgram/mL injection, 2.5 mL vial | |
AU | 1565231000168104 | elasomeran 200 microgram / 1 mL injection, 5 mL vial (medicinal product unit of use) | elasomeran 200 microgram/mL injection, 5 mL vial | |
AU | 1632661000168100 | elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL injection, 2.5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | |
AU | 1632711000168105 | elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 5 mL vial | |
AU | 1652611000168102 | famtozinameran + tozinameran (medicinal product) | tozinameran + famtozinameran | |
AU | 1652621000168109 | famtozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 15 microgram/0.3 mL + famtozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1595611000168109 | Nuvaxovid Multidose (severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen 5 microgram / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Nuvaxovid Multidose injection, 5 mL vial | |
AU | 1640411000168100 | riltozinameran + tozinameran (medicinal product) | tozinameran + riltozinameran | |
AU | 1640421000168107 | riltozinameran 15 microgram / 0.3 mL + tozinameran 15 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 15 microgram/0.3 mL + riltozinameran 15 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1595591000168104 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen (medicinal product) | COVID-19 (NVX-CoV2373) vaccine | |
AU | 1595601000168106 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen 5 microgram / 0.5 mL injection, 5 mL vial (medicinal product unit of use) | COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial | |
AU | 1659051000168101 | Spikevax Bivalent Original/Omicron BA.4-5 (davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use) | Spikevax Bivalent Original/Omicron BA.4-5 injection, 0.5 mL syringe | |
AU | 1655211000168106 | Spikevax Bivalent Original/Omicron BA.4-5 Multidose (davesomeran 25 microgram / 0.5 mL + elasomeran 25 microgram / 0.5 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron BA.4-5 Multidose injection, 2.5 mL vial | |
AU | 1632671000168106 | Spikevax Bivalent Original/Omicron Multidose (elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron Multidose injection, 2.5 mL vial | |
AU | 1632721000168103 | Spikevax Bivalent Original/Omicron Multidose (elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Spikevax Bivalent Original/Omicron Multidose injection, 5 mL vial | |
AU | 1636291000168106 | Spikevax Multidose (elasomeran 100 microgram / 1 mL) injection, 2.5 mL vial (trade product unit of use) | Spikevax Multidose 100 microgram/mL injection, 2.5 mL vial | |
AU | 1565241000168108 | Spikevax Multidose (elasomeran 200 microgram / 1 mL) injection, 5 mL vial (trade product unit of use) | Spikevax Multidose 200 microgram/mL injection, 5 mL vial | |
AU | 1525021000168100 | tozinameran (medicinal product) | tozinameran | |
AU | 1591861000168106 | tozinameran 30 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | |
AU | 1656511000168104 | tozinameran injection, 0.4 mL vial (medicinal product unit of use) | tozinameran injection, 0.4 mL vial | |
AU | 1525031000168102 | tozinameran injection, 0.45 mL vial (medicinal product unit of use) | tozinameran injection, 0.45 mL vial | |
AU | 1591701000168103 | tozinameran injection, 1.3 mL vial (medicinal product unit of use) | tozinameran injection, 1.3 mL vial | |
AU | 1530521000168101 | Vaxzevria Multidose (chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL) injection, 4 mL vial (trade product unit of use) | Vaxzevria Multidose injection, 4 mL vial | |
AU | 1527331000168106 | Vaxzevria Multidose (chimpanzee adenovirus vector encoding severe acute respiratory syndrome coronavirus-2 spike glycoprotein 50 billion viral particles / 0.5 mL) injection, 5 mL vial (trade product unit of use) | Vaxzevria Multidose injection, 5 mL vial |
